Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study.
<h4>Background</h4>The objective of this study was to estimate the economic burden attributable to laboratory-confirmed Lyme disease (LD) in Ontario, Canada and assess health outcomes associated with LD.<h4>Method</h4>We conducted a cohort study using laboratory-confirmed LD...
Main Authors: | Stephen Mac, Gerald Evans, Eleanor Pullenayegum, Samir N Patel, Beate Sander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0286552 |
Similar Items
-
Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study
by: Stephen Mac, et al.
Published: (2023-01-01) -
Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.
by: Karen O Johnson, et al.
Published: (2018-01-01) -
Laboratory Confirmation of Lyme Disease
by: Tom G Schwan, et al.
Published: (1991-01-01) -
The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
by: Stephen Mac, et al.
Published: (2019-01-01) -
Spatiotemporal trends and socioecological factors associated with Lyme disease in eastern Ontario, Canada from 2010–2017
by: Andreea M. Slatculescu, et al.
Published: (2022-04-01)